Have a feature idea you'd love to see implemented?
Let us know!
TLSI TriSalus Life Sciences Inc
Price (delayed)
$4.11
Market cap
$120.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.99
Enterprise value
$126.75M
Highlights
TLSI's EPS has soared by 99% YoY and by 95% QoQ
TriSalus Life Sciences's equity has soared by 88% YoY and by 31% from the previous quarter
TriSalus Life Sciences's net income has increased by 15% QoQ but it has decreased by 2.8% YoY
Key stats
What are the main financial stats of TLSI
Market
Valuations
Earnings
Shares outstanding
29.31M
Market cap
$120.47M
Enterprise value
$126.75M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.12
Revenue
$24.74M
EBIT
-$53.45M
EBITDA
-$52.55M
Free cash flow
-$55.74M
Per share
Balance sheet
Liquidity
EPS
-$1.99
Free cash flow per share
-$2.33
Book value per share
-$0.89
Revenue per share
$1.03
TBVPS
$1.31
Total assets
$32.43M
Total liabilities
$56.58M
Debt
$22.76M
Equity
-$24.15M
Working capital
$15.94M
Debt to equity
-0.94
Current ratio
2.33
Quick ratio
1.77
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
-212.4%
Gross margin
87.7%
Net margin
-219.7%
Operating margin
-213.4%
Return on assets
-198.3%
Return on equity
N/A
Return on invested capital
-740%
Return on capital employed
-261.6%
Return on sales
-216.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLSI stock price
How has the TriSalus Life Sciences stock price performed over time
Intraday
1.99%
1 week
-3.29%
1 month
1.48%
1 year
-14.91%
YTD
-51.36%
QTD
-10.85%
Financial performance
How have TriSalus Life Sciences's revenue and profit performed over time
Revenue
$24.74M
Gross profit
$21.68M
Operating income
-$52.79M
Net income
-$54.35M
Gross margin
87.7%
Net margin
-219.7%
The gross profit has soared by 84% YoY and by 14% QoQ
The revenue has surged by 68% year-on-year and by 13% since the previous quarter
TLSI's net margin is up by 39% year-on-year and by 25% since the previous quarter
TriSalus Life Sciences's operating income has decreased by 26% YoY but it has increased by 6% from the previous quarter
Growth
What is TriSalus Life Sciences's growth rate over time
Valuation
What is TriSalus Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
3.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.12
TLSI's EPS has soared by 99% YoY and by 95% QoQ
TriSalus Life Sciences's equity has soared by 88% YoY and by 31% from the previous quarter
The revenue has surged by 68% year-on-year and by 13% since the previous quarter
TLSI's P/S is 34% below its last 4 quarters average of 6.0
Efficiency
How efficient is TriSalus Life Sciences business performance
TriSalus Life Sciences's ROA has plunged by 191% YoY but it has increased by 27% from the previous quarter
TLSI's ROS is up by 40% YoY and by 26% QoQ
Dividends
What is TLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLSI.
Financial health
How did TriSalus Life Sciences financials performed over time
The company's total assets is 43% lower than its total liabilities
TLSI's current ratio has surged by 153% since the previous quarter
The company's total assets has surged by 93% YoY and by 81% QoQ
TLSI's debt is 194% greater than its equity
TriSalus Life Sciences's equity has soared by 88% YoY and by 31% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.